|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.57 CNY | -3.53% |
|
+5.21% | +5.39% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 4.68% | 5.16% | 14.77x | 2.77x | 0.62x | 4.89x | 8.08x | 3.24B | |
| -.--% | -.--% | 18.44x | 1.63x | 0.79x | 12.41x | 13.33x | 15.95B | |
| 0.96% | 1.2% | 23.67x | 2.62x | 0.94x | 16.66x | 16.93x | 7.16B | |
| 2.3% | 2.61% | 16.19x | 1.71x | 0.72x | 7.56x | 9.51x | 5.98B | |
| 3.16% | 3.48% | 13.55x | 2.04x | 0.87x | 6.25x | 8.19x | 3.84B | |
| 4.16% | 4.56% | 15.43x | 6.98x | 0.94x | 7.04x | 9.79x | 3.19B | |
| 5.49% | 6.25% | 14.04x | 4.26x | 1.2x | 7.28x | 13.96x | 3.15B | |
| 1.77% | 2.15% | 23.15x | 4.05x | 0.66x | 8.51x | 13.93x | 1.7B | |
| 0.01% | -.--% | -89.46x | 2.94x | 0.47x | 17.45x | 105.49x | 1.56B | |
| 4.11% | 4.63% | 12.34x | 0.88x | 0.29x | 2.85x | 5.88x | 977M | |
| 5.7% | 5.51% | 12.94x | 2.3x | 0.85x | 6.99x | 13.94x | 928M | |
| 1.36% | 1.97% | 26.95x | 7.26x | 0.96x | 13.22x | 20.96x | 796M | |
| 0.36% | 0.37% | 14.35x | 1.94x | 0.69x | 8.41x | 13.58x | 702M | |
| Average | 2.62% | 2.91% | 8.95x | 3.18x | 0.77x | 9.19x | 19.51x | 3.78B | |
| Weighted average by Cap. | 1.87% | 2.11% | 14.43x | 2.62x | 0.81x | 10.48x | 15.38x |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
